CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 15 enrolled
Drug / intervention
PARTS Programbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04713501
NCT04713501N/ACompleted

Program for Alleviating and Resolving Trauma and Stress Study (Stage 1 Pilot)

Cambridge Health Alliance·interventional·Posted Jan 19, 2021·Updated Oct 12, 2021

In Brief

A clinical study evaluating PARTS Program for Post-traumatic Stress Disorder. Completed, enrolled 15 participants across 1 site.

Detailed Summary

This single-arm pilot study (Phase 1) will test the preliminary efficacy of a virtually delivered, live-online 16-week group model of Internal Family Systems (IFS) for individuals with PTSD, called the PARTS program, on PTSD symptoms measured by Clinician-Administered PTSD Scale (CAPS-5). In addition, feasibility, acceptability, and effects on self-report PTSD and disturbances of self-organization (DSO) will be secondary outcomes.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedJan 19, 2021
Enrollment StartDec 22, 2020
Primary CompletionJul 31, 2021
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 5.5 years ago

Interventions

PARTS Programbehavioral

The PARTS Program is a 16-week group intervention model, with 8 individual clinical sessions on a biweekly basis, developed to resolve and alleviate trauma and stress for individuals diagnosed with PTSD.